Longitudinal plasma amyloid beta as a biomarker of Alzheimer's disease. - Test2 - elhamkhani - TriplyDB

Longitudinal plasma amyloid beta as a biomarker of Alzheimer's disease.

Longitudinal plasma amyloid beta as a biomarker of Alzheimer's disease.

http://www.wikidata.org/entity/Q37987083

about

The Alzheimer's Disease Neuroimaging Initiative: a review of papers published since its inception Longitudinal plasma amyloid beta in Alzheimer's disease clinical trials.2014 Update of the Alzheimer's Disease Neuroimaging Initiative: A review of papers published since its inception.The future of blood-based biomarkers for Alzheimer's disease.Novel plasma biomarker surrogating cerebral amyloid deposition.Plasma amyloid-β and risk of Alzheimer's disease in the Framingham Heart Study.Multiplex assessment of a panel of 16 serum molecules for the differential diagnosis of Alzheimer's disease The Alzheimer's disease peptide β-amyloid promotes thrombin generation through activation of coagulation factor XII.Detection of Alzheimer's disease at mild cognitive impairment and disease progression using autoantibodies as blood-based biomarkers.Plasma amyloid beta measurements - a desired but elusive Alzheimer's disease biomarker The Alzheimer's Disease Neuroimaging Initiative 2 Biomarker Core: A review of progress and plans.The Alzheimer's disease mitochondrial cascade hypothesis: progress and perspectives.Plasma biomarkers for Alzheimer's disease: much needed but tough to find.Amyloid-β as a biomarker for Alzheimer's disease: quantification methods in body fluids.Effects of super-hard rice bread blended with black rice bran on amyloid β peptide production and abrupt increase in postprandial blood glucose levels in mice.A plasma proteolysis pathway comprising blood coagulation proteases Neuro-Coagulopathy: Blood Coagulation Factors in Central Nervous System Diseases.Impaired cortical oscillatory coupling in mild cognitive impairment: anatomical substrate and ApoE4 effects.Anticoagulants inhibit proteolytic clearance of plasma amyloid beta.

P2860

Q27006831-F7D0F4CA-697A-468E-A8F2-BFBDF53872E6 Q27310276-FA192658-4667-446C-95F5-18FE38085383 Q30971403-2E216D1A-F857-432B-A134-D7AC105E5FD7 Q34026317-D6758B19-0B56-4749-AB38-A8655195611B Q35074431-CB785334-32A0-41D0-B2B5-1B979F89E142 Q35185694-255EC0F6-5678-41A3-825D-FF443CCF2FA9 Q36695912-6C6F77A6-59EC-40D4-A1B6-8CE733FF3CCB Q36909451-5DAEFA2A-719D-4695-AFE9-35BCA2C87E61 Q36934163-0476A394-C3D2-4F87-97E8-754906B61647 Q36998414-C3C1EBD0-32F1-43CF-A545-CC87B8FE1D53 Q37451440-4E518A24-AFA8-4D8D-9ABF-592D9B12FC33 Q37656554-B1E6EBE2-FD1D-426A-97C5-1326C149F501 Q38037157-195EB585-90CE-47C8-9D93-BE611D532E4A Q38543843-1368A2C1-BE9B-430A-AF2E-139B00F934CD Q39327965-ABCE1498-05CC-40E6-B5C2-F1BFA75B8570 Q39539762-CEDF8BB2-BFDA-4C3D-BCD2-D71B9CE414ED Q42696477-C595E641-7158-4AC3-ABDB-EC2CD2C24CCC Q44556621-4EF8E6C1-BEC6-4C3B-9FB9-637585760F65 Q49787919-9EE7F10D-CC90-4EDA-A848-9A8BD926A7CC

P2860

Longitudinal plasma amyloid beta as a biomarker of Alzheimer's disease.

http://www.wikidata.org/entity/Q37987083

description

article científic

@ca

article scientifique

@fr

articol științific

@ro

articolo scientifico

@it

artigo científico

@gl

artigo científico

@pt

artigo científico

@pt-br

artikel ilmiah

@id

artikull shkencor

@sq

artículo científico

@es

name

Longitudinal plasma amyloid beta as a biomarker of Alzheimer's disease.

@en

Longitudinal plasma amyloid beta as a biomarker of Alzheimer's disease.

@nl

type

label

Longitudinal plasma amyloid beta as a biomarker of Alzheimer's disease.

@en

Longitudinal plasma amyloid beta as a biomarker of Alzheimer's disease.

@nl

prefLabel

Longitudinal plasma amyloid beta as a biomarker of Alzheimer's disease.

@en

Longitudinal plasma amyloid beta as a biomarker of Alzheimer's disease.

@nl

P1433

Q37987083-1AE252FF-9165-4EE0-AF3C-01C8DD568326

P1476

Q37987083-876B5829-CF19-4433-ACC2-B0A9C711A8E5

P2093

Q37987083-0700AA1D-3A29-4937-9228-73963E3EC463

Q37987083-39B94A44-26F4-478B-8B73-B62F04C5F73A

P2860

Q37987083-0354A65D-722D-4DC7-B800-8D775A5265FA

Q37987083-08254211-DC2B-4E42-AB7E-9C641D7783BF

Q37987083-0944D7C5-54C1-48AD-A98B-5BD9E34DD023

Q37987083-097FF512-1185-4EBF-8F71-45CEE965081A

Q37987083-15A9556D-5A8F-4C6E-A184-9942BAADCBC6

Q37987083-27958AD1-3223-4DA7-8C1E-17DE4C334207

Q37987083-2DEA342E-AACE-4B94-9B82-CB27366B49F9

Q37987083-34D4C9FD-EACA-4EC4-AFCF-11D78953F9E0

Q37987083-3FB6F5A7-BE27-49C5-A986-5A4BFDB94C31

Q37987083-432B0D3F-6A3E-411D-9A0C-F8382510CD4C

P2888

Q37987083-DF1526BC-B317-4BFD-AA97-D19DBF880A1F

P304

Q37987083-E87D8655-CE8D-42A1-938D-6819D538BFD0

P31

Q37987083-DF9886CE-1A9D-40ED-9010-F2152DF1DD38

P356

Q37987083-73A91D13-8304-4C57-B99A-02C0A7225048

P433

Q37987083-16B6CDF6-4E4D-44CA-B13D-83024B0758D9

P478

Q37987083-469CFB35-DC79-4FB6-9292-DED5F53FE858

P50

Q37987083-25DC2E66-0021-4AE1-AC47-7C2F4FDE7342

Q37987083-B47107DC-3A2D-45A2-89BD-170D70CA30D6

P577

Q37987083-4697E38C-1069-4F7D-87A6-68F384FF54C8

P698

Q37987083-B8B5B614-FF87-4B31-B6E6-B67E09696275

P921

Q37987083-340B1276-C41B-4792-9916-C64112388F08

Q37987083-979BA847-85DB-4FF2-9375-783AC308CE96

P932

Q37987083-74B30219-B6E2-49EC-B8AE-013B57F19613

P356

S00702-012-0772-4

P1433

Journal of Neural Transmission

P1476

Longitudinal plasma amyloid beta as a biomarker of Alzheimer's disease.

@en

P2093

Leslie M Shaw

http://www.w3.org/2001/XMLSchema#string

Robert A Rissman

http://www.w3.org/2001/XMLSchema#string

P2860

Beta-secretase cleavage of Alzheimer's amyloid precursor protein by the transmembrane aspartic protease BACE

Purification and cloning of amyloid precursor protein beta-secretase from human brain

Secreted amyloid beta-protein similar to that in the senile plaques of Alzheimer's disease is increased in vivo by the presenilin 1 and 2 and APP mutations linked to familial Alzheimer's disease

BACE1, a major determinant of selective vulnerability of the brain to amyloid-beta amyloidogenesis, is essential for cognitive, emotional, and synaptic functions.

Age-dependent changes in brain, CSF, and plasma amyloid (beta) protein in the Tg2576 transgenic mouse model of Alzheimer's disease.

Proteomics-derived cerebrospinal fluid markers of autopsy-confirmed Alzheimer's disease.

Clearance of Alzheimer's amyloid-ss(1-40) peptide from brain by LDL receptor-related protein-1 at the blood-brain barrier

Beta-amyloid (Abeta) protein in cerebrospinal fluid as a biomarker for Alzheimer's disease.

Olfactory copy number association with age at onset of Alzheimer disease

Association of plasma beta-amyloid level and cognitive reserve with subsequent cognitive decline

P2888

s00702-012-0772-4

P304

843-850

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S00702-012-0772-4

http://www.w3.org/2001/XMLSchema#string

P433

7

http://www.w3.org/2001/XMLSchema#string

P478

119

http://www.w3.org/2001/XMLSchema#string

P50

John Q. Trojanowski

P577

2012-02-22T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

22354745

http://www.w3.org/2001/XMLSchema#string

P921

Alzheimer's disease

P932

4305447

http://www.w3.org/2001/XMLSchema#string